
Taro Pharmaceutical Industries Investor Relations Material
Latest events

Q4 2024
20 May, 2024

Q3 2024
25 Jan, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Taro Pharmaceutical Industries Ltd
Access all reports
Taro Pharmaceutical Industries Ltd is a pharmaceutical company that develops, manufactures, and markets a range of prescription and over-the-counter medications. The company specializes in dermatological products, while also offering treatments in areas such as cardiology, neurology, and anti-inflammatory therapies. Taro focuses on producing generic pharmaceuticals, with a portfolio that includes creams, ointments, tablets, and liquids. Its products are distributed to markets globally, primarily in North America. The company is headquartered in Haifa Bay, Israel, and its shares are listed on the NYSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TARO
Country
🇺🇸 United States